logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Suvichada Assawakosri

chulalongkorn university
H指数:15
被引数:709

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection
VACCINES
IF3.4
2024-02-102
OAAI
Suntronwong, Nungruthai; Kanokudom, Sitthichai; Auphimai, Chompoonut; Thongmee, Thanunrat; Assawakosri, Suvichada; Vichaiwattana, Preeyaporn; Yorsaeng, Ritthideach; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Nilyanimit, Pornjarim; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Poovorawan, Yong
Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination

异源新型冠状病毒肺炎加强疫苗在健康成人中接种两剂CoronaVac疫苗后3-4个月对Omicron BA.1，BA.2和BA.4/5变体的免疫原性和持久性

HELIYON
IF3.6
2024-01-011
OAAI
Assawakosri, Suvichada; Kanokudom, Sitthichai; Suntronwong, Nungruthai; Chansaenroj, Jira; Auphimai, Chompoonut; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Thongmee, Thanunrat; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Klinfueng, Sirapa; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Honsawek, Sittisak; Poovorawan, Yong
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
SCIENTIFIC REPORTS
IF3.9
2023-09-2010
OAAI
Chansaenroj, Jira; Suntronwong, Nungruthai; Kanokudom, Sitthichai; Assawakosri, Suvichada; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Wongsrisang, Lakana; Thongmee, Thanunrat; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Yorsaeng, Ritthideach; Katanyutanon, Apirat; Thanasopon, Wichai; Bhunyakitikorn, Wichan; Sonthichai, Chaninan; Angsuwatcharakorn, Piyada; Withaksabut, Withak; Wanlapakorn, Nasamon; Sudhinaraset, Natthinee; Poovorawan, Yong
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis

新型冠状病毒肺炎疫苗接种和感染后的SARS-CoV-2抗体动态: 真实世界横断面分析

VACCINES
IF3.4
2023-06-308
OAAI
Yorsaeng, Ritthideach; Atsawawaranunt, Kamolthip; Suntronwong, Nungruthai; Kanokudom, Sitthichai; Chansaenroj, Jira; Assawakosri, Suvichada; Nilyanimit, Pornjarim; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Wongsrisang, Lakkhana; Auphimai, Chompoonut; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Poovorawan, Yong
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years
JOURNAL OF MEDICAL VIROLOGY
IF4.6
2023-04-273
PRE
Wanlapakorn, Nasamon; Kanokudom, Sitthichai; Phowatthanasathian, Harit; Chansaenroj, Jira; Suntronwong, Nungruthai; Assawakosri, Suvichada; Yorsaeng, Ritthideach; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Chantima, Warangkana; Pakchotanon, Pattarakul; Duangchinda, Thaneeya; Sudhinaraset, Natthinee; Poovorawan, Yong
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5

12种不同的三剂量方案后的第四剂mRNA新型冠状病毒肺炎疫苗: 对Omicron BA.4/BA.5的安全性和免疫原性

VACCINES
IF3.4
2023-03-016
OAAI
Kanokudom, Sitthichai; Chansaenroj, Jira; Suntronwong, Nungruthai; Assawakosri, Suvichada; Yorsaeng, Ritthideach; Nilyanimit, Pornjarim; Aeemjinda, Ratchadawan; Khanarat, Nongkanok; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Thongmee, Thanunrat; Srimuan, Donchida; Thatsanathorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Honsawek, Sittisak; Poovorawan, Yong
Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination

异源CoronaVac/AZD1222疫苗接种后，增强mRNA和腺病毒载体疫苗对omicron BA.1和BA.2免疫反应的影响

JOURNAL OF MEDICAL VIROLOGY
IF4.6
2022-08-1018
OA
Suntronwong, Nungruthai; Kanokudom, Sitthichai; Auphimai, Chompoonut; Assawakosri, Suvichada; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Chansaenroj, Jira; Puenpa, Jiratchaya; Nilyanimit, Pornjarim; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Poovorawan, Yong
Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
DIAGNOSTICS
IF3.3
2022-07-2215
OAAI
Suntronwong, Nungruthai; Assawakosri, Suvichada; Kanokudom, Sitthichai; Yorsaeng, Ritthideach; Auphimai, Chompoonut; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Chansaenroj, Jira; Nilyanimit, Pornjarim; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Poovorawan, Yong
Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine

两剂bbibp-corv疫苗和第三次加强剂量的病毒载体和mRNA新型冠状病毒肺炎疫苗对初次免疫的成年人的Delta和Omicron变体的免疫原性

VACCINES
IF3.4
2022-07-0319
OAAI
Chansaenroj, Jira; Suntronwong, Nungruthai; Kanokudom, Sitthichai; Assawakosri, Suvichada; Yorsaeng, Ritthideach; Vichaiwattana, Preeyaporn; Klinfueng, Sirapa; Wongsrisang, Lakana; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Thongmee, Thanunrat; Auphimai, Chompoonut; Nilyanimit, Pornjarim; Wanlapakorn, Nasamon; Sudhinaraset, Natthinee; Poovorawan, Yong
Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination

在接受两剂CoronaVac疫苗接种的健康成年人中，异源助推器后对Omicron变体的中和活性

JOURNAL OF INFECTIOUS DISEASES
IF4.5
2022-03-1047
OA
Assawakosri, Suvichada; Kanokudom, Sitthichai; Suntronwong, Nungruthai; Auphimai, Chompoonut; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Thongmee, Thanunrat; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Klinfueng, Sirapa; Yorsang, Ritthideach; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Mongkolsapaya, Juthathip; Honsawek, Sittisak; Poovorawan, Yong
COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
VACCINES
IF3.4
2022-03-0319
OAAI
Suntronwong, Nungruthai; Yorsaeng, Ritthideach; Puenpa, Jiratchaya; Auphimai, Chompoonut; Thongmee, Thanunrat; Vichaiwattana, Preeyaporn; Kanokudom, Sitthichai; Duangchinda, Thaneeya; Chantima, Warangkana; Pakchotanon, Pattarakul; Assawakosri, Suvichada; Nilyanimit, Pornjarim; Klinfueng, Sirapa; Wongsrisang, Lakkhana; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Poovorawan, Yong
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

健康成人异源和同源灭活和腺病毒载体新型冠状病毒肺炎疫苗方案的安全性和免疫原性: 一项前瞻性队列研究

HUMAN VACCINES & IMMUNOTHERAPEUTICS
IF3.5
2022-02-2456
OAAI
Wanlapakorn, Nasamon; Suntronwong, Nungruthai; Phowatthanasathian, Harit; Yorsaeng, Ritthideach; Vichaiwattana, Preeyaporn; Thongmee, Thanunrat; Auphimai, Chompoonut; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Assawakosri, Suvichada; Kanokudom, Sitthichai; Poovorawan, Yong
Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine

灭活疫苗，病毒载体和mRNA新型冠状病毒肺炎疫苗的第三次加强剂量在完全免疫的健康成年人中的安全性和免疫原性

VACCINES
IF3.4
2022-01-0671
OAAI
Kanokudom, Sitthichai; Assawakosri, Suvichada; Suntronwong, Nungruthai; Auphimai, Chompoonut; Nilyanimit, Pornjarim; Vichaiwattana, Preeyaporn; Thongmee, Thanunrat; Yorsaeng, Ritthideach; Srimuan, Donchida; Thatsanatorn, Thaksaporn; Klinfueng, Sirapa; Sudhinaraset, Natthinee; Wanlapakorn, Nasamon; Honsawek, Sittisak; Poovorawan, Yong

研究方向

暂未获取到该数据
Y
Yong Poovorawan
H 指数:64论文数:977被引数:2.2万
N
Nungruthai Suntronwong
H 指数:21论文数:86被引数:1,830
S
Sitthichai Kanokudom
H 指数:15论文数:64被引数:788
N
Nasamon Wanlapakorn
H 指数:29论文数:173被引数:2,900
T
Thanunrat Thongmee
H 指数:22论文数:94被引数:1,486
R
Ritthideach Yorsaeng
H 指数:20论文数:76被引数:1,194
P
Preeyaporn Vichaiwattana
H 指数:24论文数:112被引数:1,697
D
Donchida Srimuan
H 指数:15论文数:64被引数:721
N
Natthinee Sudhinaraset
H 指数:18论文数:63被引数:912
P
Pornjarim Nilyanimit
H 指数:15论文数:73被引数:776